Evidence map›Paper›PMID 34584184›Full record

ArticleScientific reports2021

Redox status of cysteines does not alter functional properties of human dUTPase but the Y54C mutation involved in monogenic diabetes decreases protein stability.

Judit Eszter Szabó, Kinga Nyíri, Dániel Andrási, Judit Matejka, Olivér Ozohanics, Beáta Vértessy

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. DUT (p.Y116C)-Mutation-Induced Thrombocytopenia in Rabbits.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Judit Eszter Szabó *Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Budapest, Hungary. szabo.judit.eszter@ttk.hu.
Kinga Nyíri *Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Budapest, Hungary.
Dániel AndrásiDepartment of Applied Biotechnology and Food Sciences, Budapest University of Technology and Economics, Budapest, Hungary.
Judit MatejkaInstitute of Enzymology, RCNS, Eötvös Loránd Research Network, Budapest, Hungary.
Olivér OzohanicsDepartment of Biochemistry, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary.
Beáta VértessyInstitute of Enzymology, RCNS, Eötvös Loránd Research Network, Budapest, Hungary. vertessy@kutatok.org.
Budapest University of Technology and Economics · HUHungarian Research NetworkInstitute of Molecular Life Sciences · HUSemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently it was proposed that the redox status of cysteines acts as a redox switch to regulate both the oligomeric status and the activity of human dUTPase. In a separate report, a human dUTPase point mutation, resulting in a tyrosine to cysteine substitution (Y54C) was identified as the monogenic cause of a rare syndrome associated with diabetes and bone marrow failure. These issues prompt a critical investigation about the potential regulatory role of cysteines in the enzyme. Here we show on the one hand that independently of the redox status of wild-type cysteines, human dUTPase retains its characteristic trimeric assembly and its catalytic activity. On the other hand, the Y54C mutation did not compromise the substrate binding and the catalytic properties of the enzyme at room temperature. The thermal stability of the mutant protein was found to be decreased, which resulted in the loss of 67% of its activity after 90 min incubation at the physiological temperature in contrast to the wild-type enzyme. In addition, the presence or absence of reducing agents had no effect on hDUT

Indexed as

Amino Acid SubstitutionCloning, MolecularCrystallography, X-RayCysteineDiabetes MellitusHumansModels, MolecularMutagenesis, Site-DirectedOxidation-ReductionPoint MutationProtein StabilityPyrophosphatasesRecombinant ProteinsTyrosineCysteinedUTP pyrophosphatasePyrophosphatasesRecombinant ProteinsTyrosine

Identifiers

PMID34584184
PMCPMC8478915
OpenAlexW3202762672

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.